Manuka honey, produced from the nectar of the Leptospermum scoparium plant native to New Zealand, has a long history of use in wound care and has gained considerable scientific attention in recent decades. Research suggests that its antimicrobial properties, attributed largely to the naturally occurring compound methylglyoxal, may help inhibit a broad spectrum of bacteria, including antibiotic-resistant strains such as MRSA. Studies indicate that medical-grade Manuka honey and specialized honey-based dressings can support wound healing by maintaining a moist environment, reducing inflammation, and promoting tissue regeneration. While traditional use also extends to digestive health, the strongest body of clinical evidence currently centers on topical wound applications, and those interested in exploring its use for specific health concerns may wish to consult a healthcare provider.
Compare this supplementThese are commonly referenced dosage ranges for this supplement. They are not medical recommendations. Always consult a healthcare provider before supplementing.
| Form | Dose range | Frequency | Studied for | Source |
|---|---|---|---|---|
| Liquid | 20–30 g | Daily | digestive health and H. pylori inhibition | Based on RCTs examining oral intake for gastrointestinal antimicrobial effects |
| Liquid | 1–2 g | Three times daily | oral mucositis and throat soothing | Used in clinical studies for chemotherapy-induced mucositis management |
| Topical | — | Daily | diabetic foot ulcers and chronic wounds | Supported by RCTs using standardized UMF/MGO-rated Manuka honey dressings |
| Topical | — | Once or twice daily | wound healing, burns, and skin ulcers | Common in clinical trials using medical-grade Manuka honey dressings (e.g., Medihoney) |